NPI: 1255579629 · ZEPHYRHILLS, FL 33542 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/23/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/23/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,837 | $2.42M |
| 2019 | 27,322 | $3.23M |
| 2020 | 33,881 | $4.40M |
| 2021 | 24,372 | $1.75M |
| 2022 | 12,708 | $1.22M |
| 2023 | 2,039 | $207K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 36,273 | 1,565 | $4.14M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,824 | 2,103 | $3.74M |
| J1270 | Injection, doxercalciferol, 1 mcg | 21,501 | 1,332 | $2.39M |
| A4657 | Syringe, with or without needle, each | 4,233 | 1,794 | $832K |
| J1756 | Injection, iron sucrose, 1 mg | 6,889 | 1,311 | $616K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 2,987 | 185 | $344K |
| 85041 | 2,504 | 1,390 | $238K | |
| 85048 | 2,388 | 1,335 | $230K | |
| 83970 | 2,030 | 1,049 | $227K | |
| 83540 | 1,229 | 745 | $126K | |
| 82728 | 1,081 | 677 | $120K | |
| 83550 | 1,082 | 674 | $117K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 657 | 303 | $47K |
| 82108 | 268 | 166 | $29K | |
| G0008 | Administration of influenza virus vaccine | 117 | 81 | $13K |
| 90662 | 51 | 40 | $6K | |
| 90674 | 45 | 29 | $6K |